Skip to main content
RAPP filings

Corporate insider profile

Krishnaswamy Yeleswaram Filing Activity

Latest reported as Chief Development Officer of Rapport Therapeutics, Inc. (RAPP).

Purchase filings
0
Reported companies
1
Net open-market value
-$1,504,667.54
Latest transaction
Apr 17, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Apr 17, 2026Rapport Therapeutics, Inc. (RAPP)Chief Development OfficerSale20,225$39.99$808,844
Apr 14, 2026Rapport Therapeutics, Inc. (RAPP)Chief Development OfficerSale19,865$35.03$695,823